Hormonal assessment of the pituitary-gonadal axis revealed decreased levels of testosterone (TES), luteinizing hormone (LH), follicle-stimulating hormone (FSH), and androstenedione (AND) establishing the diagnosis of hypogonadotropic hypogonadism. Here, BRD2 is linked to hypogonadotropic hypogonadism.